Trials / Terminated
TerminatedNCT00584688
A Double Blind, Placebo Controlled Trial of Quetiapine in Anorexia Nervosa, a Dual Site Study
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- University of South Florida · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Research studies raise the possibility that medications such as quetiapine may improve mood or reduce obsessions in people with anorexia nervosa and may even help to normalize appetite. The medication quetiapine also known as seroquel works by activating certain systems in the brain, such as ones known as dopamine and serotonin chemical systems in the brain.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | quetiapine | quetiapine dosage will be titrated to subject tolerance beginning at 50 mg every 24 hours upwards to 400 mg every 24 hours. |
Timeline
- Start date
- 2007-02-01
- Primary completion
- 2009-06-01
- Completion
- 2009-08-01
- First posted
- 2008-01-02
- Last updated
- 2012-06-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00584688. Inclusion in this directory is not an endorsement.